BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 31194956)

  • 21. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
    Luo W; Wang T; Hong C; Yang YC; Chen Y; Cen J; Xie SQ; Wang CJ
    Eur J Med Chem; 2016 Oct; 122():17-26. PubMed ID: 27343850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effects of different curcuminoids on β-amyloid protein, β-amyloid precursor protein and β-site amyloid precursor protein cleaving enzyme 1 in swAPP HEK293 cells.
    Liu H; Li Z; Qiu D; Gu Q; Lei Q; Mao L
    Neurosci Lett; 2010 Nov; 485(2):83-8. PubMed ID: 20727383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.
    Vafadarnejad F; Karimpour-Razkenari E; Sameem B; Saeedi M; Firuzi O; Edraki N; Mahdavi M; Akbarzadeh T
    Bioorg Chem; 2019 Nov; 92():103192. PubMed ID: 31446239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Identification of Biochanin A as a Potent and Selective β-Site App-Cleaving Enzyme 1 (Bace1) Inhibitor.
    Youn K; Park JH; Lee J; Jeong WS; Ho CT; Jun M
    Nutrients; 2016 Oct; 8(10):. PubMed ID: 27754406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Alzheimer's disease activity of compounds from the root bark of Morus alba L.
    Kuk EB; Jo AR; Oh SI; Sohn HS; Seong SH; Roy A; Choi JS; Jung HA
    Arch Pharm Res; 2017 Mar; 40(3):338-349. PubMed ID: 28093699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice.
    Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J
    Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study.
    Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a BACE1 Binding Peptide Candidate for the Prevention of Amyloid Beta in Alzheimer's Disease.
    Read J; Suphioglu C
    Cell Physiol Biochem; 2019; 53(2):413-428. PubMed ID: 31415717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
    Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of multi-target compounds as AChE, BACE1, and amyloid-β(1-42) oligomerization inhibitors: in silico and in vitro studies.
    Hernández-Rodríguez M; Correa-Basurto J; Martínez-Ramos F; Padilla-Martínez II; Benítez-Cardoza CG; Mera-Jiménez E; Rosales-Hernández MC
    J Alzheimers Dis; 2014; 41(4):1073-85. PubMed ID: 24762947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative Evaluation of the Antioxidant and Anti-Alzheimer's Disease Potential of Coumestrol and Puerarol Isolated from Pueraria lobata Using Molecular Modeling Studies.
    Koirala P; Seong SH; Jung HA; Choi JS
    Molecules; 2018 Mar; 23(4):. PubMed ID: 29597336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imino-2H-Chromene Based Derivatives as Potential Anti-Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study.
    Attarroshan M; Firuzi O; Iraji A; Sharifi S; Tavakkoli M; Vesal M; Khoshneviszadeh M; Pirhadi S; Edraki N
    Chem Biodivers; 2022 Jan; 19(1):e202100599. PubMed ID: 34786830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in the Generation of Amyloid-β Due to Salvianolic Acid B by Modulating BACE1 Activity.
    Durairajan SSK; Chirasani VR; Shetty SG; Iyaswamy A; Malampati S; Song J; Liu L; Huang J; Senapati S; Li M
    Curr Alzheimer Res; 2017; 14(11):1229-1237. PubMed ID: 28413985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.
    Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q
    J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibitory effect of chitosan oligosaccharides on β-site amyloid precursor protein cleaving enzyme 1 (BACE1) in HEK293 APPswe cells.
    Dai X; Chang P; Li X; Gao Z; Sun Y
    Neurosci Lett; 2018 Feb; 665():80-85. PubMed ID: 29175631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
    Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of some 2-(3-oxo-5,6-diphenyl-1,2,4-triazin-2(3H)-yl)-N-phenylacetamide hybrids as MTDLs for Alzheimer's disease therapy.
    Waiker DK; Verma A; Gajendra TA; Namrata ; Roy A; Kumar P; Trigun SK; Srikrishna S; Krishnamurthy S; Davisson VJ; Shrivastava SK
    Eur J Med Chem; 2024 May; 271():116409. PubMed ID: 38663285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.
    Ghobadian R; Mahdavi M; Nadri H; Moradi A; Edraki N; Akbarzadeh T; Sharifzadeh M; Bukhari SNA; Amini M
    Eur J Med Chem; 2018 Jul; 155():49-60. PubMed ID: 29857276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.